科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/11 | 5,980 | 6,090 | 5,970 | 6,070 | +80 | +1.3% | 127,600 |
2017/07/10 | 5,950 | 6,020 | 5,930 | 5,990 | +120 | +2% | 115,400 |
2017/07/07 | 5,930 | 5,950 | 5,870 | 5,870 | -110 | -1.8% | 189,300 |
2017/07/06 | 5,960 | 6,020 | 5,950 | 5,980 | ±0 | ±0% | 116,200 |
2017/07/05 | 6,020 | 6,030 | 5,950 | 5,980 | -40 | -0.7% | 143,000 |
2017/07/04 | 6,080 | 6,080 | 5,990 | 6,020 | -30 | -0.5% | 136,900 |
2017/07/03 | 6,060 | 6,090 | 6,030 | 6,050 | -80 | -1.3% | 132,700 |
2017/06/30 | 6,030 | 6,160 | 6,010 | 6,130 | +80 | +1.3% | 283,800 |
2017/06/29 | 5,980 | 6,070 | 5,970 | 6,050 | +100 | +1.7% | 195,700 |
2017/06/28 | 5,950 | 5,980 | 5,940 | 5,950 | -10 | -0.2% | 117,600 |
2017/06/27 | 5,940 | 5,970 | 5,910 | 5,960 | -20 | -0.3% | 120,500 |
2017/06/26 | 5,970 | 5,990 | 5,940 | 5,980 | ±0 | ±0% | 90,300 |
2017/06/23 | 5,960 | 6,000 | 5,950 | 5,980 | +20 | +0.3% | 105,500 |
2017/06/22 | 5,980 | 5,980 | 5,940 | 5,960 | +30 | +0.5% | 86,900 |
2017/06/21 | 5,930 | 5,960 | 5,890 | 5,930 | ±0 | ±0% | 115,100 |
2017/06/20 | 5,970 | 5,970 | 5,920 | 5,930 | +10 | +0.2% | 162,900 |
2017/06/19 | 5,880 | 5,950 | 5,880 | 5,920 | +40 | +0.7% | 103,100 |
2017/06/16 | 5,950 | 5,950 | 5,870 | 5,880 | -40 | -0.7% | 164,000 |
2017/06/15 | 5,870 | 5,930 | 5,850 | 5,920 | ±0 | ±0% | 229,500 |
2017/06/14 | 5,990 | 6,010 | 5,910 | 5,920 | -70 | -1.2% | 141,300 |
2017/06/13 | 5,970 | 6,040 | 5,970 | 5,990 | +40 | +0.7% | 171,500 |
2017/06/12 | 5,950 | 5,950 | 5,900 | 5,950 | -30 | -0.5% | 239,000 |
2017/06/09 | 6,020 | 6,060 | 5,970 | 5,980 | -50 | -0.8% | 170,700 |
2017/06/08 | 6,100 | 6,100 | 6,020 | 6,030 | -60 | -1% | 206,100 |
2017/06/07 | 6,140 | 6,150 | 6,080 | 6,090 | -60 | -1% | 142,600 |
2017/06/06 | 6,280 | 6,300 | 6,140 | 6,150 | -170 | -2.7% | 209,600 |
2017/06/05 | 6,220 | 6,330 | 6,160 | 6,320 | -200 | -3.1% | 425,100 |
2017/06/02 | 6,550 | 6,560 | 6,490 | 6,520 | -40 | -0.6% | 179,100 |
2017/06/01 | 6,430 | 6,560 | 6,430 | 6,560 | +180 | +2.8% | 154,100 |
2017/05/31 | 6,480 | 6,500 | 6,360 | 6,380 | -150 | -2.3% | 193,100 |
2017/05/30 | 6,570 | 6,590 | 6,510 | 6,530 | +10 | +0.2% | 116,900 |
2017/05/29 | 6,560 | 6,590 | 6,510 | 6,520 | -40 | -0.6% | 105,000 |
2017/05/26 | 6,580 | 6,600 | 6,540 | 6,560 | -10 | -0.2% | 131,000 |
2017/05/25 | 6,580 | 6,630 | 6,550 | 6,570 | +10 | +0.2% | 105,600 |
2017/05/24 | 6,600 | 6,610 | 6,510 | 6,560 | -40 | -0.6% | 184,000 |
2017/05/23 | 6,620 | 6,650 | 6,560 | 6,600 | +40 | +0.6% | 146,700 |
2017/05/22 | 6,600 | 6,600 | 6,530 | 6,560 | -50 | -0.8% | 153,800 |
2017/05/19 | 6,680 | 6,680 | 6,560 | 6,610 | -70 | -1% | 154,300 |
2017/05/18 | 6,750 | 6,800 | 6,630 | 6,680 | +30 | +0.5% | 195,500 |
2017/05/17 | 6,680 | 6,710 | 6,610 | 6,650 | -60 | -0.9% | 155,600 |
2017/05/16 | 6,800 | 6,820 | 6,670 | 6,710 | -60 | -0.9% | 211,500 |
2017/05/15 | 6,730 | 6,780 | 6,720 | 6,770 | ±0 | ±0% | 188,900 |
2017/05/12 | 6,760 | 6,830 | 6,740 | 6,770 | ±0 | ±0% | 192,700 |
2017/05/11 | 6,870 | 6,880 | 6,740 | 6,770 | -120 | -1.7% | 275,900 |
2017/05/10 | 6,940 | 6,970 | 6,650 | 6,890 | -60 | -0.9% | 494,000 |
2017/05/09 | 6,810 | 6,950 | 6,800 | 6,950 | +80 | +1.2% | 151,000 |
2017/05/08 | 6,810 | 6,900 | 6,810 | 6,870 | +160 | +2.4% | 272,900 |
2017/05/02 | 6,690 | 6,740 | 6,680 | 6,710 | +40 | +0.6% | 119,600 |
2017/05/01 | 6,610 | 6,670 | 6,580 | 6,670 | +60 | +0.9% | 157,100 |
2017/04/28 | 6,550 | 6,610 | 6,540 | 6,610 | +100 | +1.5% | 144,100 |
1901~
1950
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム